Status:
UNKNOWN
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
Lead Sponsor:
Stanford University
Conditions:
Bone Marrow Transplantation
Respiratory Insufficiency
Eligibility:
All Genders
1-21 years
Phase:
PHASE2
PHASE3
Brief Summary
For children undergoing bone marrow transplantation, respiratory failure is a devastating complication, with mortality expectations well above 60%. The researchers have devised a novel strategy that m...
Detailed Description
For children undergoing bone marrow transplantation, respiratory failure carries mortality expectations well above 60%. The researchers have published preliminary evidence that continuous hemofiltrati...
Eligibility Criteria
Inclusion
- hematopoietic stem cell recipient
- respiratory failure fulfilling ARDS criteria
- mechanical ventilation (invasive / non-invasive)
Exclusion
- extracorporeal membrane oxygenation (ECMO)
- predominance of congestive heart failure
- code status: a patient must be willing to accept invasive mechanical ventilation if clinically indicated
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2008
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT00120575
Start Date
January 1 2005
End Date
September 1 2008
Last Update
December 5 2006
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital and Research Center
Oakland, California, United States, 94609
2
Children's Healthcare of Atlanta @ Egleston
Atlanta, Georgia, United States, 30322
3
Duke University
Durham, North Carolina, United States, 27710
4
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104